Clinical trial
Safety Study of Galantamine in Tic Disorders
NCT00226824 · Parkinson's Disease and Movement Disorders Center, Other · Terminated
Key facts
| NCT number | NCT00226824 |
|---|---|
| Title | Safety Study of Galantamine in Tic Disorders |
| Official title | Pilot Examination of Galantamine in the Management of Tic Disorders |
| Lead sponsor | Parkinson's Disease and Movement Disorders Center, Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tourette's Syndrome, Motor Tic Disorder, Vocal Tic Disorder |
| Intervention type | Drug |
| Interventions | galantamine |
| Enrollment | 1 |
| Start date | Sep 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 27, 2005 |
| Last update posted | Aug 25, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: